About Longeveron, Inc. 
Longeveron, Inc.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available
Shareholding Snapshot
Shareholding Compare (%holding) 
Majority shareholders
Domestic Funds
Domestic Funds
Held in 3 Schemes (2.27%)
Foreign Institutions
Held by 10 Foreign Institutions (0.5%)
Strategic Entities with highest holding
Highest Public shareholder
Management
Designation
No Data
Revenue and Profits:
Net Sales:
0 Million
(Quarterly Results - Jun 2025)
Net Profit:
-5 Million
Pharmaceuticals & Biotechnology
USD 18 Million (Micro Cap)
NA (Loss Making)
NA
0.00%
-0.77
-146.48%
1.39






